PTGX - Protagonist Therapeutics, Inc
94.83
3.530 3.722%
Share volume: 745,540
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$91.30
3.53
0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-06-2024 | 11-07-2024 | 02-21-2025 | 05-06-2025 | 08-06-2025 | 11-06-2025 | 02-25-2026 | |
| Total revenue | 254.953 M | 4.167 M | 4.675 M | 170.638 M | 28.321 M | 5.546 M | 4.712 M | 7.437 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 254.953 M | 4.167 M | 4.675 M | 170.638 M | 28.321 M | 5.546 M | 4.712 M | 7.437 M | |
| -98.37% | 12.19% | 3,550.01% | -83.40% | -80.42% | -15.04% | 57.83% | |||
| Operating expenses | 48.644 M | 42.960 M | 46.128 M | 43.858 M | 47.631 M | 47.587 M | 51.133 M | 57.792 M | |
| Selling general and admin | 14.910 M | 9.440 M | 10.158 M | 8.954 M | 11.738 M | 10.551 M | 11.130 M | 11.434 M | |
| Research and development | 33.734 M | 33.520 M | 35.970 M | 34.904 M | 35.893 M | 37.036 M | 40.003 M | 46.358 M | |
| Total expenses | 48.644 M | 42.960 M | 46.128 M | 43.858 M | 47.631 M | 47.587 M | 51.133 M | 57.792 M | |
| -11.68% | 7.37% | -4.92% | 8.60% | -0.09% | 7.45% | 13.02% | |||
| Operating income | 206.309 M | -38.793 M | -41.453 M | 126.780 M | -19.310 M | -42.041 M | -46.421 M | -50.355 M | |
| Ebit | 206.290 M | -38.696 M | -41.312 M | 126.811 M | -19.228 M | -42.005 M | -46.388 M | -50.479 M | |
| Pretax income | 210.666 M | -31.292 M | -33.630 M | 133.664 M | -11.655 M | -34.599 M | -39.339 M | -43.718 M | |
| -114.85% | 7.47% | -497.45% | -108.72% | 196.86% | 13.70% | 11.13% | |||
| Income tax | 3.326 M | -676.000 K | -420.000 K | 1.990 M | 0.000 | 172.000 K | 0.000 | 666.000 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 207.340 M | -30.616 M | -33.210 M | 131.674 M | -11.655 M | -34.771 M | -39.339 M | -44.384 M | |
| -114.77% | -8.47% | 496.49% | -108.85% | -198.34% | -13.14% | -12.82% |